Alvogen and Lotus Launch the First Generic Equivalent to Revlimid(TM) Capsules in Selected European


PINE BROOK, New Jersey, February 13, 2019 /PRNewswire/ -- Global pharmaceutical company, Alvogen, today announced the launch of the first generic equivalent ... Lees verder

Bron: ANP Pers support
Geplaatst: 13 feb 2019 - 10:01